Mogrify

0 followers


Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.

Industries

+4

Headquarters

Stage

Employees

Links

Org chart

Darrin M. Disley
Director & CEO

Darrin M. Disley

Collapse
Aida Moreno-Moral
Director of Cell Informatics
Alastair Kilgour
Investment Director
Alex Bladon
Associate Director
Conor Johnston
General Counsel
David Anderson
Director of Technology Group
David Matthews
Senior Director of Immunology and Ophthalmology at Mogrify
Helen Glen
Director of Financial Planning and Analysis
Julian Gough
Chief Scientific Advisor
Lorenz Mayr
NED - Non-Executive Director
Mark Cavanagh
Chief of Staff
Michael Newton
Head of IP
Owen Rackham
Co-founder
Sarah B.
Human Resources Manager